Cargando…

Performance of Multidrug-Resistant Tuberculosis Surveillance in Yemen: Interview Study

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is a major challenge to ending TB occurrence by 2035. In Yemen, the 2011 survey showed an MDR-TB prevalence of 1.4% among new cases and 14.4% among previously treated cases. The National Tuberculosis Control Program (NTCP) established four MDR-TB...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulmughni, Jihan, Mahyoub, Esam Mohammed, Alaghbari, Abdulaziz Thabit, Al Serouri, Abdulwahed Abdelgabar, Khader, Yousef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797968/
https://www.ncbi.nlm.nih.gov/pubmed/31584002
http://dx.doi.org/10.2196/14294
_version_ 1783459946559438848
author Abdulmughni, Jihan
Mahyoub, Esam Mohammed
Alaghbari, Abdulaziz Thabit
Al Serouri, Abdulwahed Abdelgabar
Khader, Yousef
author_facet Abdulmughni, Jihan
Mahyoub, Esam Mohammed
Alaghbari, Abdulaziz Thabit
Al Serouri, Abdulwahed Abdelgabar
Khader, Yousef
author_sort Abdulmughni, Jihan
collection PubMed
description BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is a major challenge to ending TB occurrence by 2035. In Yemen, the 2011 survey showed an MDR-TB prevalence of 1.4% among new cases and 14.4% among previously treated cases. The National Tuberculosis Control Program (NTCP) established four MDR-TB sentinel surveillance sites in 2013 to monitor the MDR-TB situation. In Yemen, the 2011 survey showed an MDR-TB prevalence of 1.4% among new cases and 14.4% among previously treated cases. The NTCP established four MDR-TB sentinel surveillance sites in 2013 to monitor the MDR-TB situation. OBJECTIVE: This study aimed to assess the performance of MDR-TB surveillance and determine its strengths and weaknesses. METHODS: We used the updated Center for Diseases Control and Prevention guidelines for evaluating public health surveillance systems. Interviews were conducted with NTCP managers and Regional MDR-TB centers’ staff using a semistructured questionnaire. We used a 5-point Likert scale to assess the usefulness and other attributes (eg, simplicity and flexibility). The mean percentage was calculated for each attribute and used for the final rank of the performance: poor (<60%), average (60%-80%), and good (>80%). RESULTS: The MDR-TB surveillance system achieved good performance in usefulness (87%), acceptability (82%), and data quality (91%); average performance in flexibility (61%) and simplicity (72%); and poor performance in stability (55%). The overall performance score was average (74%). Although strong commitment, good monitoring, and well-trained staff are the main strengths, depending on an external fund is a major weakness along with unavailability of the MDR-TB unit at the governorate level. CONCLUSIONS: Although the MDR-TB surveillance system has achieved an average overall performance, more efforts are required to improve its stability by ensuring constant power supply to enable laboratories to perform necessary diagnostic and follow-up tests. Gradual replacement of donors’ funds by the government is recommended. Scaling up of MDR-TB services and removing access barriers are crucial.
format Online
Article
Text
id pubmed-6797968
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-67979682019-10-25 Performance of Multidrug-Resistant Tuberculosis Surveillance in Yemen: Interview Study Abdulmughni, Jihan Mahyoub, Esam Mohammed Alaghbari, Abdulaziz Thabit Al Serouri, Abdulwahed Abdelgabar Khader, Yousef JMIR Public Health Surveill Original Paper BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is a major challenge to ending TB occurrence by 2035. In Yemen, the 2011 survey showed an MDR-TB prevalence of 1.4% among new cases and 14.4% among previously treated cases. The National Tuberculosis Control Program (NTCP) established four MDR-TB sentinel surveillance sites in 2013 to monitor the MDR-TB situation. In Yemen, the 2011 survey showed an MDR-TB prevalence of 1.4% among new cases and 14.4% among previously treated cases. The NTCP established four MDR-TB sentinel surveillance sites in 2013 to monitor the MDR-TB situation. OBJECTIVE: This study aimed to assess the performance of MDR-TB surveillance and determine its strengths and weaknesses. METHODS: We used the updated Center for Diseases Control and Prevention guidelines for evaluating public health surveillance systems. Interviews were conducted with NTCP managers and Regional MDR-TB centers’ staff using a semistructured questionnaire. We used a 5-point Likert scale to assess the usefulness and other attributes (eg, simplicity and flexibility). The mean percentage was calculated for each attribute and used for the final rank of the performance: poor (<60%), average (60%-80%), and good (>80%). RESULTS: The MDR-TB surveillance system achieved good performance in usefulness (87%), acceptability (82%), and data quality (91%); average performance in flexibility (61%) and simplicity (72%); and poor performance in stability (55%). The overall performance score was average (74%). Although strong commitment, good monitoring, and well-trained staff are the main strengths, depending on an external fund is a major weakness along with unavailability of the MDR-TB unit at the governorate level. CONCLUSIONS: Although the MDR-TB surveillance system has achieved an average overall performance, more efforts are required to improve its stability by ensuring constant power supply to enable laboratories to perform necessary diagnostic and follow-up tests. Gradual replacement of donors’ funds by the government is recommended. Scaling up of MDR-TB services and removing access barriers are crucial. JMIR Publications 2019-10-03 /pmc/articles/PMC6797968/ /pubmed/31584002 http://dx.doi.org/10.2196/14294 Text en ©Jihan Abdulmughni, Esam Mohammed Mahyoub, Abdulaziz Thabit Alaghbari, Abdulwahed Abdelgabar Al Serouri, Yousef Khader. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 03.10.2019 https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on http://publichealth.jmir.org, as well as this copyright and license information must be included.
spellingShingle Original Paper
Abdulmughni, Jihan
Mahyoub, Esam Mohammed
Alaghbari, Abdulaziz Thabit
Al Serouri, Abdulwahed Abdelgabar
Khader, Yousef
Performance of Multidrug-Resistant Tuberculosis Surveillance in Yemen: Interview Study
title Performance of Multidrug-Resistant Tuberculosis Surveillance in Yemen: Interview Study
title_full Performance of Multidrug-Resistant Tuberculosis Surveillance in Yemen: Interview Study
title_fullStr Performance of Multidrug-Resistant Tuberculosis Surveillance in Yemen: Interview Study
title_full_unstemmed Performance of Multidrug-Resistant Tuberculosis Surveillance in Yemen: Interview Study
title_short Performance of Multidrug-Resistant Tuberculosis Surveillance in Yemen: Interview Study
title_sort performance of multidrug-resistant tuberculosis surveillance in yemen: interview study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797968/
https://www.ncbi.nlm.nih.gov/pubmed/31584002
http://dx.doi.org/10.2196/14294
work_keys_str_mv AT abdulmughnijihan performanceofmultidrugresistanttuberculosissurveillanceinyemeninterviewstudy
AT mahyoubesammohammed performanceofmultidrugresistanttuberculosissurveillanceinyemeninterviewstudy
AT alaghbariabdulazizthabit performanceofmultidrugresistanttuberculosissurveillanceinyemeninterviewstudy
AT alserouriabdulwahedabdelgabar performanceofmultidrugresistanttuberculosissurveillanceinyemeninterviewstudy
AT khaderyousef performanceofmultidrugresistanttuberculosissurveillanceinyemeninterviewstudy